Correlation Between Nkarta and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Nkarta and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Moleculin Biotech, you can compare the effects of market volatilities on Nkarta and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Moleculin Biotech.
Diversification Opportunities for Nkarta and Moleculin Biotech
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nkarta and Moleculin is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Nkarta i.e., Nkarta and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Nkarta and Moleculin Biotech
Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the Moleculin Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Nkarta Inc is 1.68 times less risky than Moleculin Biotech. The stock trades about -0.29 of its potential returns per unit of risk. The Moleculin Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 262.00 in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nkarta Inc vs. Moleculin Biotech
Performance |
| Timeline |
| Nkarta Inc |
| Moleculin Biotech |
Nkarta and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nkarta and Moleculin Biotech
The main advantage of trading using opposite Nkarta and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Nkarta vs. Eliem Therapeutics | Nkarta vs. Scpharmaceuticals | Nkarta vs. Milestone Pharmaceuticals | Nkarta vs. Seres Therapeutics |
| Moleculin Biotech vs. Eliem Therapeutics | Moleculin Biotech vs. Scpharmaceuticals | Moleculin Biotech vs. Milestone Pharmaceuticals | Moleculin Biotech vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |